Investment Management Corp of Ontario Sells 20,763 Shares of Waters Corporation $WAT

Investment Management Corp of Ontario decreased its stake in Waters Corporation (NYSE:WAT) by 25.7% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 59,956 shares of the medical instruments supplier’s stock after selling 20,763 shares during the period. Investment Management Corp of Ontario owned 0.10% of Waters worth $22,773,000 as of its most recent filing with the SEC.

Several other hedge funds have also added to or reduced their stakes in WAT. Brighton Jones LLC raised its position in Waters by 112.9% in the fourth quarter. Brighton Jones LLC now owns 1,269 shares of the medical instruments supplier’s stock worth $471,000 after acquiring an additional 673 shares during the period. Integrated Wealth Concepts LLC raised its position in Waters by 2.9% in the first quarter. Integrated Wealth Concepts LLC now owns 1,048 shares of the medical instruments supplier’s stock worth $386,000 after acquiring an additional 30 shares during the period. Goldman Sachs Group Inc. raised its position in Waters by 3.6% in the first quarter. Goldman Sachs Group Inc. now owns 200,051 shares of the medical instruments supplier’s stock worth $73,733,000 after acquiring an additional 6,976 shares during the period. Empowered Funds LLC raised its position in Waters by 16.6% in the first quarter. Empowered Funds LLC now owns 1,126 shares of the medical instruments supplier’s stock worth $415,000 after acquiring an additional 160 shares during the period. Finally, Sivia Capital Partners LLC bought a new stake in Waters in the second quarter worth about $232,000. Institutional investors own 94.01% of the company’s stock.

Waters Stock Performance

Waters stock opened at $357.02 on Thursday. The firm’s 50 day simple moving average is $340.94 and its 200 day simple moving average is $348.84. The company has a current ratio of 1.79, a quick ratio of 1.13 and a debt-to-equity ratio of 0.32. The firm has a market capitalization of $35.06 billion, a PE ratio of 45.36, a price-to-earnings-growth ratio of 2.18 and a beta of 1.21. Waters Corporation has a 1-year low of $275.05 and a 1-year high of $414.15.

Waters (NYSE:WAT) last posted its earnings results on Tuesday, May 5th. The medical instruments supplier reported $2.70 earnings per share for the quarter, topping analysts’ consensus estimates of $2.31 by $0.39. The business had revenue of $1.27 billion for the quarter, compared to analyst estimates of $1.20 billion. Waters had a net margin of 11.91% and a return on equity of 15.60%. Waters’s revenue was up 91.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.25 EPS. Waters has set its Q2 2026 guidance at 2.950-3.050 EPS and its FY 2026 guidance at 14.400-14.600 EPS. As a group, analysts expect that Waters Corporation will post 14.51 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several analysts have commented on the stock. Robert W. Baird set a $387.00 price objective on shares of Waters in a research report on Wednesday, May 6th. Wolfe Research assumed coverage on shares of Waters in a research report on Tuesday, June 2nd. They issued an “outperform” rating and a $425.00 price objective on the stock. Evercore raised shares of Waters from an “in-line” rating to an “outperform” rating and set a $350.00 price target on the stock in a research report on Monday, April 6th. TD Cowen boosted their price target on shares of Waters from $345.00 to $385.00 and gave the company a “hold” rating in a research report on Wednesday, May 6th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Waters in a research report on Monday, April 20th. Three investment analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat, Waters has a consensus rating of “Moderate Buy” and an average target price of $394.56.

About Waters

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.